Abstract |
Adriamycin is a potent antitumor drug that causes severe cardiotoxicity. However, the toxic mechanisms are not clear. We used a proteomics approach to analyze changes in protein profiles after adriamycin-induced changes in hemodynamic factors. Although adriamycin itself did not affect left ventricular developed pressure (LVDP) or left ventricular end diastolic pressure (LVEDP), the drug did enhance susceptibility to ischemia-reperfusion-induced changes in LVDP, LVEDP and heart rate. Adriamycin altered the expression of 52 proteins, primarily energy metabolism and cytoskeleton proteins. Adriamycin decreased the expression of the metabolism-related proteins, ATP synthase, Sdha protein, Triose phosphate isomerase 1 (TPI-1), pyruvate dehydrogenase E1 alpha1, 6-phosphofructokinase, and fructose-1,6-bisphosphatase, as did cytoskeletal proteins, such as actin. Alterations in energy metabolism and subsequent free radical production may affect cytoskeletal protein expression, producing adriamycin-induced changes in cardiac hemodynamics.
|
Authors | Yan Cui, Cheng-Shi Piao, Ki-Chan Ha, Do-Sung Kim, Geum-Hwa Lee, Hae-Kyung Kim, Soo-Wan Chae, Yong-Chul Lee, Seoung-Ju Park, Wan-Hee Yoo, Hyung-Ryong Kim, Han-Jung Chae |
Journal | Immunopharmacology and immunotoxicology
(Immunopharmacol Immunotoxicol)
Vol. 32
Issue 3
Pg. 376-86
(Sep 2010)
ISSN: 1532-2513 [Electronic] England |
PMID | 20105085
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibiotics, Antineoplastic
- Proteins
- Doxorubicin
|
Topics |
- Animals
- Antibiotics, Antineoplastic
(adverse effects, pharmacology)
- Cytoskeleton
(drug effects)
- Doxorubicin
(adverse effects, pharmacology)
- Energy Metabolism
(drug effects)
- Heart
(drug effects, physiopathology)
- Hemodynamics
(drug effects)
- Male
- Mice
- Myocardial Reperfusion Injury
(chemically induced, metabolism, physiopathology)
- Proteins
(analysis, metabolism)
- Proteomics
- Ventricular Function, Left
(drug effects)
|